Base to Base biotech podcast 29: Blood pressure and radiopharmaceuticals

This week, we have two interviews again. We talk about treating high blood pressure with CEO of George Medicines, Mark Mallon, and have a conversation with Jack Hoppin, CEO of Ratio Therapeutics, and John Babich, CSO, about the field of radiotherapeutics.

Blood pressure

Nearly half of US adults have high blood pressure and despite all the treatments already available, three in four remain uncontrolled. This is often because the traditional stepwise treatment approach stalls before reaching target blood pressure.

George Medicines believes its solution could help millions of patients achieve better outcomes, faster.

The company has developed the first and only triple combina ...